U.S. Markets closed

Cabot's (CBT) Q1 Earnings Miss, Sales Surpass Estimates

Zacks Equity Research

Cabot Corporation CBT recorded net profit of $69 million or $1.14 per share in the first quarter of fiscal 2019 (ended Dec 31, 2018), against a net loss of $122 million or $1.98 in the year-ago quarter.

Barring one-time items, adjusted earnings per share (EPS) were 87 cents, up from 93 cents in the year-ago quarter. However, the figure missed the Zacks Consensus Estimate of 90 cents.

Net sales increased around 14% year over year to $821 million in the quarter. The figure outpaced the consensus mark of $778.4 million.

According to Cabot, performance in the Reinforcement Materials and Performance Chemicals units were affected by weaker environment in China along with softer automotive demand and customer inventory destocking. Notably, the company has reached an agreement to divest the Specialty Fluids unit for $135 million.

Cabot Corporation Price, Consensus and EPS Surprise

Cabot Corporation Price, Consensus and EPS Surprise | Cabot Corporation Quote

Segment Highlights

Reinforcement Materials sales increased 18.1% year over year to $457 million in the fiscal first quarter. EBIT in the segment was $62 million, flat year over year. The benefit from improved pricing and product mix as well as higher volumes was offset by the negative impact of lower margins in China. Margins were affected by lower pricing from weak automotive demand along with a decline of feedstock costs and high inventory levels.

Sales in the Performance Chemicals inched up around 0.9% year over year to $231 million in the quarter. EBIT declined 23.4% year over year to $36 million, due to lower volumes and higher costs associated with growth investments.

Sales in the Purification Solutions went down 7.1% year over year to $65 million in the quarter, while the same in the Specialty Fluids segment rose more than three-folds on a year-over-year basis to $19 million. Performance in the Specialty Fluids segment gained from a higher level of project activity on year-over-year basis. 

Financial Position

As of Dec 31, Cabot had cash and cash equivalents of $142 million, down from $189 million a year ago. The company’s long-term debt expanded 6.3% year over year to $671 million.

Cash used by operating activities was around $39 million in the reported quarter.

Outlook

Cabot provided an update on adjusted EPS view for fiscal 2019, considering a challenging first half. It now expects adjusted EPS in the range of $4.20-$4.60, down from the previous projection of $4.35-$4.75.

The company expects the impact on automotive production from new emissions regulations in Europe and customer destocking to have sequentially lower impact in the second quarter of fiscal 2019.

Moreover, it expects Reinforcement Materials division to gain from the calendar year 2019 customer agreements. However, the unit faces headwinds like challenging environment in China and lower oil prices in the fiscal second quarter.

Price Performance

Shares of Cabot have lost 23.3% in the past year compared with the industry’s 17.5% decline.



Zacks Rank & Stocks to Consider

Cabot currently carries a Zacks Rank #4 (Sell).

A few better-ranked stocks in the basic materials space include Franco-Nevada Corporation FNV, Quaker Chemical Corporation KWR and Israel Chemicals Ltd ICL, all carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.

Franco-Nevada has an expected earnings growth rate of 9% for 2019. The company’s shares have moved up 3.6% in the past year.

Quaker Chemical has an expected earnings growth rate of 21.1% for 2019. Its shares have surged 40.8% in a year’s time.

Israel Chemicals has an expected earnings growth rate of 11.1% for 2019. Its shares have rallied 45.5% in a year’s time.

Zacks' Top 10 Stocks for 2019

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?

Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.

See Latest Stocks Today >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cabot Corporation (CBT) : Free Stock Analysis Report
 
Quaker Chemical Corporation (KWR) : Free Stock Analysis Report
 
Israel Chemicals Shs (ICL) : Free Stock Analysis Report
 
Franco-Nevada Corporation (FNV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research